China, Sept. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of Yangxin Dingji Capsules Combined with Dronedarone on the Prognosis of Patients Undergoing Radiofrequency Catheter Ablation for Atrial Fibrillation'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132434

Registration Time: 2026/09/14

Type: Interventional study

Primary Sponsor: The second hospital of hebei medical university

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=323536

Published by HT Digital Content Services with permission from Health Daily Digest....